Update date
31 Jan 2026
Shareable Research Card
Vitro Biopharma, Inc. Current Ratio
This metric view shows Vitro Biopharma, Inc. current ratio history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2025
- Latest reported value
- 0.07x
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Jan 2026
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q4 2025.
- Latest reported value on this page: 0.07x.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Current Ratio
Latest reported current ratio: 0.07x. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 16 Mar 2026.
Benchmark Context
How Current Ratio compares with peers
Vitro Biopharma, Inc. is outside the visible top 120 companies for current ratio in the current sample.
Compared with
Compared with 120 companies reporting current ratio in x. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Current Ratio is down about 41% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2017 to 30 Apr 2026.
- Nearby companies in this sample: Invesco CurrencyShares Australian Dollar Trust and Invesco CurrencyShares British Pound Sterling Trust.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Vitro Biopharma, Inc.: Current Ratio
Latest period: Q4 2025. Period end: 31 Jan 2026. Units: x. Frequency: quarterly.
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Metric Snapshot
- Latest value
- 0.07x
- Coverage range
- 30 Apr 2012 - 31 Jan 2026
- Fact rows
- 22
What This Metric Tells You
- Shows reported current ratio over 30 Apr 2012 - 31 Jan 2026.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 22 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Current Ratio levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | Invesco CurrencyShares Australian Dollar Trust (fxa) | 2,951.71x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Australian Dollar Trust Current Ratio |
| 2 | Invesco CurrencyShares British Pound Sterling Trust (fxb) | 2,830.33x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares British Pound Sterling Trust Current Ratio |
| 3 | Invesco CurrencyShares Japanese Yen Trust (fxy) | 1,729.03x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Japanese Yen Trust Current Ratio |
| 4 | Invesco CurrencyShares Euro Trust (fxe) | 1,409.58x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Euro Trust Current Ratio |
| 5 | Invesco CurrencyShares Swiss Franc Trust (fxf) | 1,010.7x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Swiss Franc Trust Current Ratio |
| 6 | Golden Growers Cooperative (ggrou) | 707.17x | Instant - 31 Mar 2026 | Open Golden Growers Cooperative Current Ratio |
Metric Details
- Metric
- Current Ratio (CurrentRatio)
- Frequency coverage
- quarterly
- Taxonomy
- ratio
- Units tracked
- x
- History range
- 30 Apr 2012 - 31 Jan 2026
- Facts on this page
- 22
- Metric definition
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- SEC metric endpoint
- Open SEC company concept
Metric identity
1 identity field
Metric coverage
3 source fields
How to read it
1 detail
Source evidence
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Vitro Biopharma, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.07x | -0.05x | -41% | 31 Jan 2026 |
| Q3 2025 | 0.05x | -0.14x | -72% | 31 Oct 2025 |
| Q2 2025 | 0.05x | -0.23x | -82% | 31 Jul 2025 |
| Q1 2025 | 0.08x | -0.32x | -79% | 30 Apr 2025 |
| Q4 2024 | 0.13x | -0.45x | -78% | 31 Jan 2025 |
| Q3 2024 | 0.19x | -0.62x | -77% | 31 Oct 2024 |
| Q2 2024 | 0.29x | -0.66x | -70% | 31 Jul 2024 |
| Q1 2024 | 0.4x | 30 Apr 2024 | ||
| Q4 2023 | 0.58x | 31 Jan 2024 | ||
| Q3 2023 | 0.81x | 31 Oct 2023 | ||
| Q2 2023 | 0.95x | 31 Jul 2023 | ||
| Q3 2014 | 0.02x | +0.01x | +38% | 31 Oct 2014 |
| Q2 2014 | 0.02x | +0x | +26% | 31 Jul 2014 |
| Q1 2014 | 0.02x | +0x | +21% | 30 Apr 2014 |
| Q4 2013 | 0.02x | +0x | +7.4% | 31 Jan 2014 |
| Q3 2013 | 0.02x | 0x | +0.17% | 31 Oct 2013 |
| Q2 2013 | 0.02x | +0x | +15% | 31 Jul 2013 |
| Q1 2013 | 0.02x | +0x | +25% | 30 Apr 2013 |
| Q4 2012 | 0.02x | 31 Jan 2013 | ||
| Q3 2012 | 0.02x | 31 Oct 2012 | ||
| Q2 2012 | 0.02x | 31 Jul 2012 | ||
| Q1 2012 | 0.01x | 30 Apr 2012 |
* marks a reported value that did not pass the local value check.